Herbamin Biolab IVS: Financial statements 2019

CVR: 39573881

Herbamin Biolab IVS (CVR 39573881) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -25,208 and a net result of DKK -25,408. Equity amounted to DKK -28,908.

Gross Profit: -25,208 kr.
Profit/Loss: -25,408 kr.
Equity: -28,908 kr.
Total Assets: 3,132 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

Herbamin Biolab IVS publishes interim reportMay 31, 2019

Herbamin Biolab IVS has published its interim report for the period May 14, 2018 – December 31, 2018.

About Herbamin Biolab IVS

Herbamin Biolab IVS was a Danish company of the type Iværksætterselskab based in Fårevejle, founded in 2018 and dissolved in 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2019, the company reported a gross profit of DKK -25,208 and a net result of DKK -25,408. Equity amounted to DKK -28,908.